ANGPTL4 and familial pancreatic carcinoma: We measured the impact of <i>ANGPTL4</i> overexpression in a common pancreatic cancer cell line, MIA PaCa-2 cells, using CRISPRa for overexpression and DsiRNA for knockdown.